Kinetic analysis of steroid 5 alpha-reductase activity at neutral pH in benign prostatic hyperplastic tissue: Evidence for type I isozyme activity in the human prostate

被引:26
作者
Span, PN [1 ]
Benraad, TJ [1 ]
Sweep, CGJ [1 ]
Smals, AGH [1 ]
机构
[1] UNIV NIJMEGEN HOSP,DEPT EXPT & CHEM ENDOCRINOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1016/0960-0760(95)00167-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In human benign prostatic hyperplastic (BPH) tissue homogenates 5 alpha-reduction of testosterone was examined at neutral pH. As Lineweaver-Burk and Eadie-Scatchard plots of estimated initial velocities against a wide range of substrate concentrations of 2 nM to 3.2 mu M were non-linear, the existence of two 5 alpha-reductase isozymes in this tissue was surmised. Indeed, enzyme parameters at pH 7.0 suggested the presence of two isozymes with affinity constants of 1995 and 11.8 nM, characteristic of the well established human steroid 5 alpha-reductase isozymes type I and II, respectively. The physiological roles of these isozyme activities remain puzzling. The specific activities, V-max, of these subtypes indicated an approx. 6-fold higher maximum velocity of type I than of type II 5 alpha-reductase in the human hyperplastic prostate at this pH. In contrast, the efficiency ratios, V-max/K-m, demonstrated that the type II isozyme had a nearly 27 times higher potential in vivo activity than the type I isozyme, and is therefore most probably quantitatively responsible for dihydrotestosterone formation at physiological testosterone levels in this tissue at neutral pH. This is the first full paper on type I 5 alpha-reductase activity in human BPH tissue. (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 28 条
[1]   STRUCTURAL AND BIOCHEMICAL-PROPERTIES OF CLONED AND EXPRESSED HUMAN AND RAT STEROID 5-ALPHA-REDUCTASES [J].
ANDERSSON, S ;
RUSSELL, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3640-3644
[2]   BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE AGING - DIFFERENCES IN TYPE-I AND TYPE-II 5-ALPHA-REDUCTASE AND STEROID-HORMONE RECEPTOR MESSENGER-RIBONUCLEIC-ACID (MESSENGER-RNA) LEVELS, BUT NOT IN INSULIN-LIKE GROWTH-FACTOR MESSENGER-RNA LEVELS [J].
BONNET, P ;
REITER, E ;
BRUYNINX, M ;
SENTE, B ;
DOMBROWICZ, D ;
DELEVAL, J ;
CLOSSET, J ;
HENNEN, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1203-1208
[3]   IMMUNOCYTOCHEMICAL LOCALIZATION OF HUMAN 5-ALPHA-REDUCTASE-2 WITH POLYCLONAL ANTIBODIES IN ANDROGEN TARGET AND NONTARGET HUMAN TISSUES [J].
EICHELER, W ;
TUOHIMAA, P ;
VILJA, P ;
ADERMANN, K ;
FORSSMANN, WG ;
AUMULLER, G .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (05) :667-675
[4]   FINASTERIDE - A SLOW-BINDING 5-ALPHA-REDUCTASE INHIBITOR [J].
FALLER, B ;
FARLEY, D ;
NICK, H .
BIOCHEMISTRY, 1993, 32 (21) :5705-5710
[5]  
Faller B., 1993, Experientia (Basel), V49, pA38
[6]   THE SYNDROME OF 5-ALPHA-REDUCTASE DEFICIENCY [J].
FRATIANNI, CM ;
IMPERATOMCGINLEY, J .
ENDOCRINOLOGIST, 1994, 4 (04) :302-314
[7]   16-UNSATURATED C19 STEROIDS - REVIEW OF THEIR CHEMISTRY, BIOCHEMISTRY AND POSSIBLE PHYSIOLOGICAL ROLE [J].
GOWER, DB .
JOURNAL OF STEROID BIOCHEMISTRY, 1972, 3 (01) :45-+
[8]   EVIDENCE THAT HUMAN PROSTATIC 5-ALPHA-REDUCTASE IS LOCATED EXCLUSIVELY IN THE NUCLEUS [J].
HOUSTON, B ;
CHISHOLM, GD ;
HABIB, FK .
FEBS LETTERS, 1985, 185 (02) :231-235
[9]   COMPARISON OF NUCLEAR 5-ALPHA-REDUCTASE ACTIVITIES IN THE STROMAL AND EPITHELIAL FRACTIONS OF HUMAN PROSTATIC TISSUE [J].
HUDSON, RW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (03) :349-353
[10]   COMPARISON OF THE NUCLEAR 5-ALPHA-REDUCTION OF TESTOSTERONE AND ANDROSTENEDIONE IN HUMAN PROSTATIC-CARCINOMA AND BENIGN PROSTATIC HYPERPLASIA [J].
HUDSON, RW ;
WHERRETT, D .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 35 (02) :231-236